Summary
Since the demonstration of cell-free fetal DNA in maternal circulation, its aberrational quantification has been explored and demonstrated in numerous clinical situations. Moreover, several centers have begun to use detection and quantification of fetal DNA to diagnose fetal genetic status with high reliability, such as fetal RhD. One of the methods for analyzing cell-free fetal DNA is quantification by using LightCycler technology. With the advent of various fluorescent reporters and greater stability of kit’s reagent, real-time quantitative polymerase chain reaction by using LightCycler technology is relatively simple and fast.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lo, Y. M., Corbetta, N., Chamberlain, P. F., et al. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485–487.
Lo, Y. M., Tein, M. s., Lau, T. K., et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62, 768–775.
Sekizawa, A., Kondo, T., Iwasaki, M., et al. (2001) Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin. Chem. 47, 1856–1858.
Lo, Y. M., Hjelm, N. M., Fidler, C., et al. (1998) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med. 339, 1734–1738.
Saito, H., Sekizawa, A., Morimoto, T., Suzuki, M., and Yanaihara, T. (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356, 1170.
Sekizawa, A., Jimbo, M., Saito, H., et al. (2003) Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am. J. Obstet. Gynecol. 188, 480–484.
Sekizawa, A., Farina, A., Sugito, Y., et al. (2004) Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin. Chem. 50, 221–224.
Lo, Y. M., Leung, T. N., Tein, M. s., et al. (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45, 184–188.
Farina, A., LeShane, E. s., Lambert-Messerlian, G. M., et al. (2003) Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin. Chem. 49, 239–242.
Sekizawa, A., Jimbo, M., Saito, H., et al. (2002) Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin. Chem. 48, 353–354.
Jimbo, M., Sekizawa, A., Sugito, Y., et al. (2003) Placenta increta: postpartum monitoring of plasma cell-free fetal DNA. Clin. Chem. 49, 1540–1541.
Sekizawa, A., Sugito, Y., Iwasaki, M., Wet et al. (2001) Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin. Chem. 47, 2164–2165.
Sugito, Y., Sekizawa, A., Farina, A., et al. (2003) Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin. Chem. 49, 1667–1669.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Purwosunu, Y., Sekizawa, A., Okai, T. (2008). Detection and Quantification of Fetal DNA in Maternal Plasma by Using LightCycler Technology. In: Hahn, S., Jackson, L.G. (eds) Prenatal Diagnosis. Methods in Molecular Biology™, vol 444. Humana Press. https://doi.org/10.1007/978-1-59745-066-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-59745-066-9_18
Publisher Name: Humana Press
Print ISBN: 978-1-58829-803-4
Online ISBN: 978-1-59745-066-9
eBook Packages: Springer Protocols